ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
AN ECONOMIC-EVALUATION OF ASTHMA IN THE UNITED-STATES
Author(s): WEISS KB, GERGEN PJ, HODGSON TA
Source: NEW ENGLAND JOURNAL OF MEDICINE    Volume: 326    Issue: 13    Pages: 862-866    Published: MAR 26 1992  
Times Cited: 692     References: 41     
Abstract: Background. Asthma is a common chronic illness. Recently, increases in morbidity and mortality due to this disease have been reported. We studied the distribution of health care resources used for asthma in order to lay the groundwork for further policy decisions aimed at reducing the economic burden of this disorder.

Methods. Estimates of direct medical expenditures and indirect costs (in 1985 dollars) were derived from data available from the National Center for Health Statistics. These cost estimates were projected to 1990 dollars.

Results. The cost of illness related to asthma in 1990 was estimated to be $6.2 billion. Inpatient hospital services represented the largest single direct medical expenditure for this chronic condition, approaching $1.6 billion. The value of reduced productivity due to loss of school days represented the largest single indirect cost, approaching $1 billion in 1990. Although asthma is often considered to be a mild chronic illness treatable with ambulatory care, we found that 43 percent of its economic impact was associated with emergency room use, hospitalization, and death. Nearly two thirds of the visits for ambulatory care were to physicians in three primary care specialties - pediatrics, family medicine or general practice, and internal medicine.

Conclusions. Potential reductions in the costs related to asthma in the United States may be identified through a closer examination of the effectiveness of care associated with each category of cost. Future health policy efforts to improve the effectiveness of primary care interventions for asthma in the ambulatory setting may reduce the costs of this common illness.

Document Type: Article
Language: English
Reprint Address: WEISS, KB (reprint author), GEORGE WASHINGTON UNIV, MED CTR, DEPT HLTH CARE SCI, RM 2B-401, 2150 PENN AVE NW, WASHINGTON, DC 20037 USA
Addresses:
1. GEORGE WASHINGTON UNIV, MED CTR, DEPT MED, WASHINGTON, DC 20037 USA
2. GEORGE WASHINGTON UNIV, CTR HLTH POLICY RES, WASHINGTON, DC 20052 USA
3. NIAID, DIV ALLERGY IMMUNOL & TRANSPLANTAT, BETHESDA, MD 20892 USA
4. CTR DIS CONTROL, NATL CTR HLTH STAT, OFF ANAL & EPIDEMIOL, HYATTSVILLE, MD USA
Publisher: MASS MEDICAL SOC, 10 SHATTUCK, BOSTON, MA 02115
Subject Category: Medicine, General & Internal
IDS Number: HK523
ISSN: 0028-4793
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo